Literature DB >> 3124457

Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections.

A Monteverde1, M T Rivano, G C Allegra, A I Monteverde, P Zigrossi, P Baglioni, M Gobbi, B Falini, G Bordin, S Pileri.   

Abstract

Twelve patients with clinical and laboratory findings typical of essential mixed cryoglobulinemia, type II (EMC II) underwent multiple liver and bone marrow biopsies. In 9 of 12 cases (all hepatitis B surface antibody-negative), routine histology revealed patent infiltration of liver portal tracts, lobules and sinusoids by small lymphocytes provided with cytological characteristics closely resembling those of the LP immunocytoma of the Kiel classification. At immunophenotyping on frozen sections, these elements expressed the CD22 antigen (marker of B cells) and bore the same type of immunoglobulin (IgM/k = 8, IgM/lambda = 1) as the monotypic component in the serum. Furthermore, in 7 of 9 patients repeated bone marrow needle biopsies showed multiple foci of infiltration by plasmacytoid cells, often with paratrabecular location. In the remaining 3 cases (all hepatitis B surface and core antigen-positive), liver biopsies were consistent with a diagnosis of cirrhosis (two) or chronic active hepatitis (one). In two of them, however, Jamshidi needle biopsy evidenced bone marrow infiltrates quite similar to those observed in the other group. On the basis of these findings, the authors discuss the hypothesis that most EMC II are substained by a low-grade malignant lymphoma.

Entities:  

Mesh:

Year:  1988        PMID: 3124457     DOI: 10.1159/000205684

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  12 in total

Review 1.  T-cell non-Hodgkin's lymphoma presenting after clearance of hepatitis C: a case report and review of the literature.

Authors:  Sindu Stephen; Marie Borum
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 2.  Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations.

Authors:  A Della Rossa; G Trevisani; S Bombardieri
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome.

Authors:  Gianguglielmo Zehender; Chiara De Maddalena; Flavia Bernini; Erika Ebranati; Giuseppe Monti; Piero Pioltelli; Massimo Galli
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

5.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

6.  Deflazacort in the treatment of haematologic disorders.

Authors:  M Gobbi; M Scudeletti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia.

Authors:  A Monteverde; M Ballarè; S Pileri
Journal:  Springer Semin Immunopathol       Date:  1997

Review 8.  The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1997

9.  Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.

Authors:  Elias Toubi; Aharon Kessel; Regina Peri; Zehava Shmuel; Ellen Bamberger; Edmond Sabo; Eli Zuckerman
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.

Authors:  Gabriele Pozzato; Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Francesca Zorat; Giulia Moratelli; Pietro Bulian; Diego Serraino; Valter Gattei
Journal:  World J Hepatol       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.